Skip to content
10-Q

Quarterly Report

Immune Design Corp.

0001437786-18-000069

← back to feed
Filed
Nov 6, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 5, 2018 48.16M sh
Capex Q3 2018 · Sep 30, 2018 $269K
Capex Q3 2018 · Sep 30, 2017 $344K
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$40.27M
Operating Cash Flow restated Q3 2018 · Sep 30, 2017 −$37.02M
Short Term Investments Q3 2018 · Sep 30, 2018 $38.85M
Short Term Investments Q3 2018 · Dec 31, 2017 $68.65M
Cash And Equivalents Q3 2018 · Sep 30, 2018 $68.54M
Cash And Equivalents Q3 2018 · Dec 31, 2017 $72.45M
Cash And Equivalents Q3 2018 · Sep 30, 2017 $28.37M
Stockholders Equity Q3 2018 · Sep 30, 2018 $104.49M
Stockholders Equity Q3 2018 · Dec 31, 2017 $139.21M
Current Liabilities Q3 2018 · Sep 30, 2018 $8.58M
Current Liabilities Q3 2018 · Dec 31, 2017 $14.52M
Current Assets Q3 2018 · Sep 30, 2018 $112.49M
Current Assets Q3 2018 · Dec 31, 2017 $153.14M
Total Assets Q3 2018 · Sep 30, 2018 $113.19M
Total Assets Q3 2018 · Dec 31, 2017 $153.83M
Sga Expense Q3 2018 · Sep 30, 2018 $3.8M
Sga Expense Q3 2018 · Sep 30, 2018 $11.8M
Sga Expense Q3 2018 · Sep 30, 2017 $3.91M
Sga Expense Q3 2018 · Sep 30, 2017 $11.93M
Rd Expense Q3 2018 · Sep 30, 2018 $11.27M
Rd Expense Q3 2018 · Sep 30, 2018 $32.58M
Rd Expense Q3 2018 · Sep 30, 2017 $10.25M
Rd Expense Q3 2018 · Sep 30, 2017 $35.15M
Net Income Q3 2018 · Sep 30, 2018 −$41.16M
Net Income Q3 2018 · Sep 30, 2017 −$39.88M
Operating Income Q3 2018 · Sep 30, 2018 −$14.64M
Operating Income Q3 2018 · Sep 30, 2018 −$42.84M
Operating Income Q3 2018 · Sep 30, 2017 −$13.66M
Operating Income Q3 2018 · Sep 30, 2017 −$40.44M
Cost Of Revenue Q3 2018 · Sep 30, 2018 $32K
Cost Of Revenue Q3 2018 · Sep 30, 2018 $179K
Cost Of Revenue Q3 2018 · Sep 30, 2017 $16K
Cost Of Revenue Q3 2018 · Sep 30, 2017 $71K